The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKrm22 Plc Regulatory News (KRM)

Share Price Information for Krm22 Plc (KRM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 27.50
Bid: 25.00
Ask: 30.00
Change: 0.00 (0.00%)
Spread: 5.00 (20.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 27.50
KRM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Consolidation of ownership of Irisium Ltd

17 Apr 2020 07:00

RNS Number : 9548J
KRM22 PLC
17 April 2020
 

KRM22 plc

 

("KRM22" or the "Company")

 

Consolidation of ownership of Irisium Ltd

 

 

KRM22 plc, (AIM: KRM) the technology and software investment company focused on risk management for capital markets, is pleased to announce that it has come to an agreement to acquire the remaining 40% stake in Irisium Ltd ("Irisium") from Cinnober Financial Technology AB ("Cinnober"), which the Company does not already own (the "Transaction") for a £0.55m convertible loan note. Nasdaq acquired Cinnober in 2019.

 

Irisium provides a turnkey market surveillance system that provides customised, market-specific alerts, tailored reports, and integrated case management to make trade surveillance efficient and straightforward. In addition to traditional market abuse scenarios, Irisium monitors high frequency trading, abusive trading patterns and entity relationships. Since the initial investment by the Company, and in addition to enhancing the Irisium market surveillance platform, the Company has successfully integrated it into the Global Risk Platform and is integrating it into the Enterprise Risk Cockpit.

 

Background to the Transaction

The Company originally acquired a 60% stake in Irisium on 5 June 2018 for a cash consideration of £1.7m. In addition, KRM22 and Cinnober (together the "Parent Companies"), provided a total debt facility (the "Debt Facility") to Irisium of £2.7m proportionate to each Parent Company's stake in Irisium on that date.

 

Under the terms of the Transaction, a total of £2.9m in debt (loans advanced to Irisium under the terms of the Debt Facility and accrued interest) together with £0.3 of Irisium other liabilities due to the Parent Companies, has been converted into ordinary shares in Irisium immediately prior to the Company consolidating its ownership of Irisium.

 

On completion of the debt to equity conversion in Irisium, the Company immediately acquired the remaining 40% stake in Irisium for a total consideration of £0.55m payable to Cinnober by way of a convertible loan note (CLN) provided by KRM22 to Cinnober. The CLN is for a one-year term and can be satisfied by either the allotment and issue of ordinary shares of the Company by no later than 31 July 2020 or settled by cash at any point in the CLN term, at the Company's sole discretion. The number of ordinary shares to be allotted to Cinnober shall be equal to £0.55m divided by £0.48 or the price at which KRM22 allots shares on any placement concluded before 31 July 2020. The interest rate payable on the CLN is 8 per cent. per annum payable quarterly. Cinnober is currently a 5.71% shareholder of KRM22. No cash consideration is payable upon announcing so is entirely cash neutral to the Company, other than future interest payments.

 

Benefits of the Transaction

The consolidation of the remaining stake in Irisium will provide the Company with full control over Irisium and allow complete integration with KRM22. The Transaction will immediately remove £0.7m of debt and liabilities from the Group's consolidated balance sheet and £1.3m of debt from the consolidated balance sheet, should the CLN is satisfied by shares, at the Company's sole discretion.

 

Acquisition Financials

Irisium is currently generating £1.6m annualised recurring revenue. For the full financial year to 31 December 2018, it achieved revenue of £1.3m and a loss before tax of £2.2m.

 

Keith Todd CBE, Executive Chairman and Chief Executive Officer of KRM22 plc commented:

 

"The transaction is a natural consequence following Nasdaq's acquisition of Cinnober. It will allow a tighter integration with the core KRM22 Global Risk Platform accelerating the customer benefits from having one platform for market risk and market surveillance."

 

For further information please contact:

 

KRM22 plc InvestorRelations@krm22.com

Keith Todd CBE, Executive Chairman and CEO

Kim Suter, CFO

 

finnCap Ltd (Nominated Adviser and Sole Broker) +44 (0)20 7220 0500

Carl Holmes / Kate Bannatyne/ Matthew Radley

Alice Lane / Sunila de Silva (ECM)

 

The information communicated in this announcement is inside information for the purposes of Article 7 of Regulation 596/2014.

 

About KRM22 plc

KRM22 is a closed-ended investment company which listed on AIM on 30 April 2018. The Company has been established with the objective of creating value for its investors through the investment in, and subsequent growth and development of, target companies in the technology and software sector, with a focus on risk management in capital markets.

 

Through its investments and the Global Risk Platform, KRM22 helps capital market companies reduce the cost and complexity of risk management. The Global Risk Platform provides applications to help address firms' regulatory, market, technology and operations risk challenges and to manage their entire enterprise risk profile.

 

Capital markets companies' partner with KRM22 to optimize risk management systems and processes, improving profitability and expanding opportunities to increase portfolio returns by leveraging risk as alpha.

 

KRM22 plc is listed on AIM and the Group is headquartered in London, with offices in several of the world's major financial centres.

 

See more about KRM22 at KRM22.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRIFMLTMTBBBLM
Date   Source Headline
3rd Jun 20197:00 amRNSFinal Results
31st May 20197:00 amRNSKRM22 announces partnership with Trailight Ltd
30th May 20197:00 amRNSAcquisition of Object+
1st May 20197:00 amRNSUpdate on Fundraising
30th Apr 20197:00 amRNSDirectorate Changes
29th Apr 20197:00 amRNSDebt Facility Secured
16th Apr 20195:30 pmRNSDirector/PDMR Shareholding
16th Apr 201910:00 amRNSKRM22 launches conduct risk training offering
11th Apr 20197:00 amRNSHolding(s) in Company
3rd Apr 20197:00 amRNSFundraising
11th Mar 20199:29 amRNSKRM22 launches Enterprise Risk Cockpit
5th Mar 20197:00 amRNSDirectorate Change
21st Jan 201911:33 amRNSResult of General Meeting
4th Jan 20197:00 amRNSNotice of GM
29th Nov 20187:00 amRNSKRM22 announces new customer contracts
6th Nov 20187:00 amRNSKRM22 announces partnership with Vector Risk
3rd Oct 201811:18 amRNSHolding(s) in Company
3rd Oct 201811:17 amRNSHolding(s) in Company
1st Oct 20181:01 pmRNSHolding(s) in Company
27th Sep 20183:52 pmRNSHolding(s) in Company
25th Sep 20185:38 pmRNSCompletion of Acquisition
25th Sep 20183:32 pmRNSAcquisition
25th Sep 20187:00 amRNSHalf-year Report
16th Aug 201810:55 amRNSChange of Registered Office
17th Jul 20187:00 amRNSSubject Matter Experts Acquired in Enterprise Risk
12th Jul 20187:00 amRNSIrisium New Customer Contract
11th Jul 20187:00 amRNSKRM22 partnership with Ascent Technologies Inc
27th Jun 20185:12 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSAcquisition
3rd May 20188:04 amRNSHolding(s) in Company
2nd May 20184:32 pmRNSDirector/PDMR Shareholding
1st May 20186:09 pmRNSHolding(s) in Company
1st May 20182:18 pmRNSHolding(s) in Company
30th Apr 20188:45 amRNSGrant of Warrant
30th Apr 20188:00 amRNSAdmission to AIM and First Day of Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.